Related references
Note: Only part of the references are listed.How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Payel Roy et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis
Yun Chen et al.
NEURON (2021)
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
Andreza Fabro de Bem et al.
FRONTIERS IN NEUROSCIENCE (2021)
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2021)
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease
Christopher Clark et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Developing the ATX(N) classification for use across the Alzheimer disease continuum
Harald Hampel et al.
NATURE REVIEWS NEUROLOGY (2021)
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
Nicholas C. Cullen et al.
NATURE COMMUNICATIONS (2021)
Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects
Femke M. Feringa et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
Carina Wattmo et al.
BMC NEUROLOGY (2020)
Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study
Aku Kaipainen et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias
Christian Sandoe Musaeus et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Role of interleukin-15 in cardiovascular diseases
Guo Lei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adults
Tengfei Guo et al.
NEUROLOGY (2020)
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders
Cyrus A. Raji et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Prediction of Alzheimer's disease biomarker status defined by the 'ATN framework' among cognitively healthy individuals: results from the EPAD longitudinal cohort study
Catherine M. Calvin et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward
Michael E. Belloy et al.
NEURON (2019)
PDGF-B Is Required for Development of the Glymphatic System
Anne Sofie Munk et al.
CELL REPORTS (2019)
Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB
Thomas S. Wingo et al.
JAMA NEUROLOGY (2019)
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease
Iris J. Broce et al.
ACTA NEUROPATHOLOGICA (2019)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
Daniel A. Nation et al.
NATURE MEDICINE (2019)
Novel Immune Features of the Systemic Inflammation Associated with Primary Hypercholesterolemia: Changes in Cytokine/Chemokine Profile, Increased Platelet and Leukocyte Activation
Aida Collado et al.
JOURNAL OF CLINICAL MEDICINE (2019)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease
Cynthia Picard et al.
NEUROBIOLOGY OF AGING (2018)
Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals Findings From the Harvard Aging Brain Study
Jennifer S. Rabin et al.
JAMA NEUROLOGY (2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future
K. Blennow et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Inflammation: the link between comorbidities, genetics, and Alzheimer's disease
Estella A. Newcombe et al.
JOURNAL OF NEUROINFLAMMATION (2018)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze et al.
NEUROLOGY (2018)
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients
Tobias Skillback et al.
NEUROBIOLOGY OF AGING (2017)
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adults
Ge Li et al.
NEUROLOGY (2017)
Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia
Fabricio Ferreira de Oliveira et al.
NEUROSCIENCE LETTERS (2017)
Markers of neuroinflammation associated with Alzheimer′s disease pathology in older adults
Julius Popp et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Central Nervous System Lipoproteins ApoE and Regulation of Cholesterol Metabolism
Robert W. Mahley
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
Jon B. Toledo et al.
BRAIN (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies
Guiyou Liu et al.
NEUROBIOLOGY OF AGING (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers
Maartje I. Kester et al.
JAMA NEUROLOGY (2014)
Arterial Stiffness and β-Amyloid Progression in Nondemented Elderly Adults
Timothy M. Hughes et al.
JAMA NEUROLOGY (2014)
Comparing Positron Emission Tomography Imaging and Cerebrospinal Fluid Measurements of β-Amyloid
Susan M. Landau et al.
ANNALS OF NEUROLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng et al.
INTERNAL MEDICINE JOURNAL (2012)
Neuroinflammation: A Common Pathway in CNS Diseases as Mediated at the Blood-Brain Barrier
Michelle A. Erickson et al.
NEUROIMMUNOMODULATION (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
CSF biomarkers predict a more malignant outcome in Alzheimer disease
A. K. Wallin et al.
NEUROLOGY (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
Blood-brain barrier: Ageing and microvascular disease-systematic review and meta-analysis
Andrew J. Farrall et al.
NEUROBIOLOGY OF AGING (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
Serum interleukin-15 concentration in patients with essential hypertension
M Kaibe et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
CJ Binder et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
